Hereditary Cancer Testing Market to 2027 - Global Analysis and Forecasts By Diagnosis Type (Biopsy, Imaging); Technology (Sequencing, PCR, Microarray); End User (Hospital, Clinics, Diagnostic Centers), and Geography


The global hereditary cancer testing market is expected to reach US$ 9,840.52 Mn in 2027 from US$ 3,967.74 Mn in 2018. The market is estimated to grow with a CAGR of 11.1% from 2019-2027. 
The market for hereditary cancer testing is expected to grow, owing to factors such as increasing prevalence of hereditary cancer and growing awareness about hereditary cancer have been boosting the market over the years. In addition, the growing demand for noninvasive methods of detection are likely to have a positive impact on the growth of the market in the coming years. However, problems in accessing whole genomic data for early detection are likely to have a negative impact on the growth of the market in the coming years.
Genetic testing helps evaluate the chance of developing cancer in a lifetime. The genetic testing is done by searching for specific mutations in genes, chromosomes, or proteins. An inherited gene mutation causes hereditary cancer. An inherited gene is the one which is passed from parent to child in a family. Various methods are used for hereditary cancer testing; it includes genetic counseling. The counseling provides a discussion regarding recommendations for preventive care and screening with the patient. They support groups and other information resources and provide emotional support to the person getting the results.
Genomic analysis is used to monitor, diagnose, treat, forecast, and prevent diseases, and promote good health in persons. The technological advances have allowed more significant integration of genomics into health care delivery, facilitating screening and molecular diagnostics along with the precise detection of microbes, and prescription and monitoring of efficiency of more accurate therapeutics. Moreover, the genome-based approaches deliver advantages, and it also come with new susceptibilities and risks concerning cybersecurity. The dependency on genome databases restricts the cyber-attacks by conceding their integrity, taking them hostage, or manipulating the data they contain. Therefore, the problem in accessing the whole genomic data for early detection is expected to create a negative impact on the overall industry at a certain extent.
Global hereditary cancer testing market is segmented by diagnosis type, technology, and end user. On the basis of diagnosis type, the market is segmented into biopsy and imaging. On the basis of technology, the market is segmented into sequencing, PCR, and microarray. Based on end user, the market is segmented into diagnostic centers, hospital, and clinics. In 2018, the imaging held the largest share in the market, by diagnosis type.
Some of the major primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), Centers for Medicare & Medicaid Services (CMS), National Institute of Cancer Prevention and Research (NICPR), National Cancer Institute, Canadian Institutes of Health Research (CIHR), Spanish Society of Medical Oncology (SEOM), and others.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Hereditary Cancer Testing Market - By Diagnosis Type
1.3.2 Global Hereditary Cancer Testing Market - By Technology
1.3.3 Global Hereditary Cancer Testing Market - By End User
1.3.4 Global Hereditary Cancer Testing Market - By Geography
2. Global Hereditary Cancer Testing Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Hereditary Cancer Testing Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert Opinions
4.4 Hereditary Cancer Testing - Price Analysis (US$)
4.5 Reimbursement Scenario (US)
4.6 Population Screening Data
5. Global Hereditary Cancer Testing Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Hereditary Cancer
5.1.2 Growing Awareness About Hereditary Cancer
5.2 Key Market Restraints
5.2.1 Problems in Accessing Whole Genomic Data for Early Detection
5.3 Key Market Opportunities
5.3.1 Growing Demand for Noninvasive Methods of Detection
5.4 Future Trends
5.4.1 Preference For Personalized Medicines
5.5 Impact Analysis
6. Hereditary Cancer Testing Market - Global Analysis
6.1 Global Hereditary Cancer Testing Market Revenue Forecasts And Analysis
6.2 Global Hereditary Cancer Testing Market, By Geography - Forecasts And Analysis
6.3 Performance of Key Players
7. Global Hereditary Cancer Testing Market Analysis-  by Diagnosis Type
7.1 Overview
7.2 Global Hereditary Cancer Testing Market, By Diagnosis Type 2018 & 2027 (%)
7.3 Biopsy Market
7.3.1 Overview
7.3.2 Global Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.3 Blood Sample Market
7.3.3.1 Overview
7.3.3.2 Global Blood Sample Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.4 Cheek Swab Sample Market
7.3.4.1 Overview
7.3.4.2 Global Cheek Swab Sample Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Imaging Market
7.4.1 Overview
7.4.2 Global Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
8. Global Hereditary Cancer Testing Market Analysis-  by Technology
8.1 Overview
8.2 Global Hereditary Cancer Testing Market, By Technology 2018 & 2027 (%)
8.3 Sequencing Market
8.3.1 Overview
8.3.2 Global Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Polymerase Chain Reaction (PCR) Market
8.4.1 Overview
8.4.2 Global Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Microarray Market
8.5.1 Overview
8.5.2 Global Microarray Market Revenue and Forecasts to 2027 (US$ Mn)
9. Global Hereditary Cancer Testing Market Analysis -  by End User
9.1 Overview
9.2 Global Hereditary Cancer Testing Market, By End User 2018 & 2027 (%)
9.3 Diagnostic Centers Market
9.3.1 Overview
9.3.2 Global Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Hospitals Market
9.4.1 Overview
9.4.2 Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Clinics Market
9.5.1 Overview
9.5.2 Global Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
10. Hereditary Cancer Testing Market Revenue and Forecasts to 2027 - Geographical Analysis
10.1 North America Hereditary Cancer Testing Market
10.1.1 Overview
10.1.2 North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.3 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.1.3.1 North America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.1.4 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)
10.1.5 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.6 North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
10.1.7 US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.1 US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.2 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.1.7.2.1 US Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.1.7.3 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.7.4 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.8 Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.1 Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.2 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.1.8.2.1 Canada Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.1.8.3 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.8.4 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.9 Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.1 Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.2 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.1.9.2.1 Mexico Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.1.9.3 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.9.4 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2 Europe Hereditary Cancer Testing Market
10.2.1 Overview
10.2.2 Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.3 Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.3.1 Europe Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.4 Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.5 Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.6 Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
10.2.7 UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.7.1 UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.7.2 UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.7.2.1 UK Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.7.3 UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.7.4 UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.8 Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.8.1 Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.8.2 Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.8.2.1 Germany Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.8.3 Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.8.4 Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.9 France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9.1 France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9.2 France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.9.2.1 France Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.9.3 France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.9.4 France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.10 Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.10.1 Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.10.2 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.10.2.1 Italy Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.10.3 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.10.4 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.11 Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11.1 Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11.2 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.2.11.2.1 Spain Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.2.11.3 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.2.11.4 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3 Asia Pacific Hereditary Cancer Testing Market
10.3.1 Overview
10.3.2 Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.3 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type  (US$ Mn)
10.3.3.1 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.4 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.5 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3.6 Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
10.3.7 China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.7.1 China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.7.2 China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.7.2.1 China Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.7.3 China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.7.4 China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3.8 India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8.1 India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8.2 India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.8.2.1 India Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.8.3 India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.8.4 India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3.9 Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.9.1 Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.9.2 Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.9.2.1 Japan Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.9.3 Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.9.4 Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3.10 Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10.1 Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10.2 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.10.2.1 Australia Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.10.3 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.10.4 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.3.11 South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.11.1 South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.11.2 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.3.11.2.1 South Korea Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.3.11.3 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3.11.4 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.4 Middle East & Africa Hereditary Cancer Testing Market
10.4.1 Overview
10.4.2 Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.3 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.4.3.1 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.4.4 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.5 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.4.6 Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
10.4.7 South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7.1 South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7.2 South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.4.7.2.1 South Africa Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.4.7.3 South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.7.4 South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.4.8 Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.8.1 Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.8.2 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.4.8.2.1 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.4.8.3 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.8.4 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.4.9 UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.9.1 UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.9.2 UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.4.9.2.1 UAE Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.4.9.3 UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.9.4 UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.5 South And Central America Hereditary Cancer Testing Market
10.5.1 Overview
10.5.2 South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.3 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.5.3.1 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.5.4 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027,  By Technology (US$ Mn)
10.5.5 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.5.6 South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027,  By Country (%)
10.5.7 Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.7.1 Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.7.2 Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.5.7.2.1 Argentina Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.5.7.3 Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.5.7.4 Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.5.8 Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8.1 Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8.2 Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
10.5.8.2.1 Brazil Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
10.5.8.3 Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.5.8.4 Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11. Hereditary Cancer Testing Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
11.3 Organic Growth Strategies
11.3.1 Overview
11.3.2 Product Launch
11.3.3 Product Approval
11.3.4 Others
11.4 Inorganic Growth Strategies
11.4.1 Overview
11.4.2 Partnership
11.4.3 Agreement & Collaboration
11.4.4 Acquisition
12. Hereditary Cancer Testing Market-Key Company Profiles
12.1 Hologic Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Koninklijke Philips N.V.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Quest Diagnostics Incorporated
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Myriad Genetics, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Cancer Genetics Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Invitae Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Myogenes
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Strand Life Sciences Pvt. Ltd.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Pathway Genomics Corporation
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 CENTOGENE AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms

LIST OF TABLES Table 1. CPT Codes for Hereditary Cancer Tests Table 2. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 3. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 4. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 5. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 6. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 7. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 8. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 9. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 10. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 11. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 12. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 13. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 14. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 15. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 16. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 17. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 18. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 19. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 20. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 21. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 22. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 23. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 24. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 25. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 26. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 27. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 28. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 29. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 30. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 31. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 32. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 33. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 34. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 35. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 36. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 37. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 38. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 39. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 40. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 41. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 42. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 43. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 44. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 45. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 46. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 47. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 48. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 49. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 50. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 51. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 52. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 53. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 54. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 55. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 56. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 57. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 58. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 59. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 60. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 61. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 62. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 63. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 64. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 65. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 66. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 67. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 68. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 69. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 70. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 71. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 72. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 73. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 74. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 75. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 76. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 77. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 78. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 79. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 80. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 81. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 82. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 83. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 84. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 85. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 86. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 87. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 88. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 89. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 90. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn) Table 91. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn) Table 92. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn) Table 93. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn) Table 94. Recent Product Launch in the Hereditary Cancer Testing Market Table 95. Recent Product Approval in the Hereditary Cancer Testing Market Table 96. Recent Other Growth Strategies in the Hereditary Cancer Testing Market Table 97. Partnerships in the Hereditary Cancer Testing Market Table 98. Agreement & Collaboration in the Hereditary Cancer Testing Market Table 99. Acquisitions in the Hereditary Cancer Testing Market Table 100. Glossary of Terms, Hereditary Cancer Testing Market

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Other Reports by The Insight Partners

UAE Ice Cream Market to 2027 - Country Analysis and Forecasts by Product Type (Impulse Ice Cream, Take-Home Ice Cream, and Artisanal Ice Cream); Distribution Channel (Supermarket/Hypermarket, Convenience Store, Specialist Store, and Others)

The UAE ice cream market is accounted to US$ 118.6 Mn in 2018 and is expected to grow at a CAGR of 5.5% during the forecast period 2019 ? 2027, to account for US$ 191.3 Mn by 2027. Long summers and hot climate conditions have bolstered the growth of ...

Moringa Products Market to 2027 - Global Analysis and Forecasts by Product (Leaf Powder, Tea, Oil, Seeds, Others); Application (Dietary Supplements, Pharmaceuticals, Cosmetics, Others)

The global Moringa products market accounted for US$ 4,506.6 Mn in 2018 and is expected to grow at a CAGR of 8.5% during the forecast period 2019 - 2027, to account for US$ 9,290.1 Mn by 2027. Moringa is a plant found in sub-Himalayan areas such as I...

Rice Seed Market to 2027 - Global Analysis and Forecasts by Type (Open-Pollinated Varieties (OPV), and Hybrid); Hybridization Technique (Two-line system, and Three-line system); Treatment (Treated, and Untreated); Grain size (Long grains, Medium-sized grains, and Short grains)

The global rice seeds market accounted for US$. 5,506.8 Mn in 2018 and is expected to grow at a CAGR of 7.0% during the forecast period 2019 - 2027, to account to US$ 10,036.0 Mn by 2027. Rice is a staple food in many major countries, especially in t...

Photomask Market to 2027 - Global Analysis and Forecasts by Type (Reticle, Master Mask, Copy Mask); Application (Semiconductor and IC, Discrete, Optoelectronics, Display Device, MEMS, and Others); End-User Vertical (Semiconductor & IC, Flat Panel Display)

The global photomask market was valued at US$ 4.0 Bn in 2018 and is expected to reach US$ 5.9 Bn by 2027 with a CAGR growth rate of 4.5% in the forecast period from 2019 to 2027. Owing to the rapid rise in semiconductor and IC devices along with fla...

Air Transport Used Serviceable Material Market to 2027 - Global Analysis and Forecasts by Product Type (Engine, Component, and Airframe); Aircraft Type (Narrowbody Aircraft, Widebody Aircraft, Business Jets, and Regional Jets); Provider (OEM and Non-OEM)

The global air transport used serviceable material market accounted for US$ 4,980.2 in 2018 and is expected to grow at a CAGR of 5.9% over the forecast period 2019-2027, to account for US$ 8,307.9 Mn by 2027. The operational performance of the global...

New Biotechnology Reports

Publisher: The Insight Partners